Crisaborole shortage status
No active shortage currently reported by the regulators Mederti tracks — 1 anticipated notice on file.
Last updated 6 Nov 2026 · sourced from official medicines regulators
- Generic name (INN)
- Crisaborole
- Brand names
- STAQUIS crisaborole 2% w/w ointment tube
- ATC code
- D11AH06
- Class
- Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
Recent shortage history
- Australia: resolved (began 27 Feb 2026)
- Australia: resolved 17 Mar 2026 (began 26 Feb 2026)
Frequently asked questions
Is Crisaborole currently in shortage?
No active shortage of Crisaborole is currently reported by any of the national medicines regulators Mederti tracks. Shortages can emerge quickly — this page updates daily from official sources.
Where does this Crisaborole shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Related medicines
Tacrolimus-Monohydrate · Alitretinoin · Dupilumab · Tralokinumab · Adbry · Abrocitinib
Get alerted when Crisaborole status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.